J. Jeffrey Marshall, M.D., Medical Director of Cardiac Catheterization Labs at Northeast Georgia Medical Center (NGMC), is overseeing the hospital’s robotic angioplasty program. NGMC is the first – and currently the only – hospital in the state regularly performing the procedure, which uses the CorPath 200 System.
“It’s remarkable to be the first hospital in the state for this groundbreaking advancement in heart care, and, since we were part of the clinical trial for the robotic equipment, we already have more than a year of experience with these procedures,” says Dr. Marshall. “This is the future of heart care.”
Interventional cardiologists sit behind a lead-shielded cockpit during robotic angioplasty, versus standing at the procedure table during traditional angioplasty, and use digital controls to operate the CorPath System as it guides stents and balloons through the catheter and into the patient’s arteries. Robotic angioplasty offers several benefits versus traditional procedures:
• Improved precision when placing stents in arteries
• Provides an extra set of “hands,” which don’t get tired, during longer procedures
• Less radiation exposure for physicians and staff
“Robotic angioplasty may open the doors to new possibilities and more complex procedures as the technology evolves,” says Mark Leimbach, M.D., Chair of the Department of Cardiology and an interventional cardiologist with NGHC. “Coronary artery disease is the leading cause of death in the United States, but the implementation of this new technology shows we are thinking outside the box, pushing the boundaries and doing everything we can to try to save the lives of heart patients.”